Highest-materiality recent filing
On Dec 10, 2024, CEO A. Stone Douglass purchased 1,000 shares of Series C Preferred at $0.10/share, each carrying 200,000 votes.
Digipath completes sale of Digipath Labs' assets to DPL NV LLC for $2.3M
Sale closed on Feb 20, 2024, after Nevada CCB approval on Jan 18, 2024.
Digipath agrees to sell cannabis testing lab assets for $2.3M; director resigns
Asset purchase price $2.3M cash; adjustments based on working capital above/below $150K.
Digipath appoints Stone Douglass to board, Todd Denkin as President
Stone Douglass appointed to Board on July 1, 2021; received option for 1M shares at $0.06 exercise price.
The Company appointed A. Stone Douglass, the current Chairman, Chief Financial Officer and Secretary as well as a Director of the Company, to the additional roles of President and Chief Executive Officer of the Company effective February 29, 2024.
On February 28, 2024, Todd Denkin resigned his positions as President of Digipath, Inc. (the “Company”) and its wholly-owned subsidiary, Digipath Labs, Inc., effective the close of business on the same date to pursue other professional opportunities.
On May 2, 2023, Bruce Raben submitted a letter to the Company resigning from his position as a director of the Company.
On August 16, 2021, A. Stone Douglass, 74, who has served as a member of the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”) since July 1, 2021, was appointed to serve as the Company’s Chief Financial Officer.
On July 1, 2021, the Board appointed Todd Denkin to serve as the President of the Company.
On July 1, 2021, A. Stone Douglass, 73, was appointed to the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”).
Max materiality 0.85 · Median 0.50 · Most common event other_material